Monday 18 December, 2023
ABL Diagnostics keeps innovating and developing its Research & Development activities through a new line of PCR detection assays, called CRISPRChek, using the disruptive CRISPR technology.First CRISPRChek prototypes to be focusing on HIV & SARS-CoV-2 detection and quantification.Ambitions to position such innovation as an alternative to current qPCR detection methodologies used in all molecular biology laboratories…
Read More
About The Author
